to see the effect of epidurally administered dexamethasone on pain relief during labour when used as an additive to local anaesthetic and opioid combinatio
- Registration Number
- CTRI/2015/02/005558
- Lead Sponsor
- Government medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
•American Society of Anesthesiologists (ASA) grade I and II
•Age >18 years
•Primigravida
•Single gestation
•Cephalic presentation at >= 37 completed weeks of gestation
•In early spontaneous labour (cervical dilation <= 5 cm)
•Baseline pain score > 30 (on a 0-100 Visual analog scale)
•Able to use PCEA pump
•Requesting epidural analgesia for labour
•Refusal by parturient.
•Parturients who had received oral or parenteral analgesics in the last 4 hours.
•Systemic and local sepsis.
•Deranged coagulation profile.
•Preterm labour.( <37th completed week i.e., <259 days)
•Obstetric complications (e.g., premature rupture of amniotic membranes).
•Foetus with a non re-assuring non-stress test
•Foetus with known or suspected congenital abnormalities
•Allergy to study drugs, i.e.,levobupivacaine, fentanyl or dexamethasone
•Patient with Diabetes (either pre-existing or gestational) or history of immunosuppression
•Patient already receiving steroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method